Transplantation Market Size, Share, & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2022 - 2030

Transplantation Market Size, Share, & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2022 - 2030

Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 30.9 billion by the year 2030, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market.

Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market’s growth during the forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for the management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products and surgical instruments has majorly contributed to the expansion of the sector.

In addition, the introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports an increase in the number of organ transplant procedures.

Transplantation Market Report Highlights

  • Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
  • Tissue products segment is also expected to rise at the highest CAGR owing to advancements in transplantation products
  • Tissue transplant segment held the largest revenue share in the market, because of the rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
  • The transplant centers segment is projected to expand at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
  • The hospitals segment dominated the market in terms of revenue in 2021 owing to a large number of transplant procedures performed in hospitals
  • North America was the leading regional sector in 2021 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
  • Existence of a large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product type
1.1.2. Application type
1.1.3. End use
1.1.4. Region scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Transplantation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.4.3. Key opportunities prioritized
3.4.3.1. Key opportunities prioritized, by Product
3.4.3.2. Key opportunities prioritized, by application
3.4.3.3. Key opportunities prioritized, by end use
3.5. Transplantation Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Tissue products
4.1.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.2. Immunosuppressive drugs
4.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.3. Preservation Solutions
4.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Organ transplant
5.1.2. Tissue transplant
5.2. Product Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Transplantation Market by Application Type Outlook
5.4.1. Organ transplant
5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.4.2. Tissue transplant
5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Transplantation Market: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Transplantation centers
6.1.3. Others
6.2. Product Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Transplantation MarEnd-UseEnd Use Channel Outlook
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. Transplantation centers
6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Transplantation Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2021 & 2030
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Procedure benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Procedure benchmarking
8.3.5.4. Strategic initiatives
8.3.6. AbbVie Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Procedure benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Zimmer Biomet
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Procedure benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Novartis
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Procedure benchmarking
8.3.8.4. Strategic initiatives
8.3.9. 21 st Century Medicine
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Procedure benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biolife Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Procedure benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Teva Pharmaceutical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Procedure benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Veloxis Pharmaceuticals
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Procedure benchmarking
8.3.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings